Rayze­Bio warned of po­ten­tial iso­tope sup­ply is­sues be­fore BMS deal

Rayze­Bio ad­vised in­vestors last year it could face prob­lems se­cur­ing ac­tini­um iso­tope from a Russ­ian sup­pli­er that it re­lies on for in­ter­na­tion­al stud­ies.

Bris­tol My­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.